Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2017 Filed Feb 14, 2017 23:04 UTC |
BLUM PETER HDirector
|
GrantOption to Purchase Common Stock · Derivative | 30,000 | $4.79 Strike: $4.79 | $143,700.00 |
DisclosureSEC source: 0001209191-17-010746 · doc4.xml · derivative · entry 1 BLUM PETER H · CIK 0001062154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: MII Common Stock · 30,000 shares Expires 2027-02-10 F1 · derivative.exercise_date: Options vest 1/3 on February 10,2018, 1/3 on February 10,2019 and 1/3 on February 10,2020. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:56 UTC |
GLANVILLE THOMAS SDirector
|
GrantOption to Purchase Common Stock · Derivative | 21,000 | $4.79 Strike: $4.79 | $100,590.00 |
DisclosureSEC source: 0001209191-17-010720 · doc4.xml · derivative · entry 1 GLANVILLE THOMAS S · CIK 0001192319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: MII Common Stock · 21,000 shares Expires 2027-02-10 F1 · derivative.exercise_date: Options vest 1/3 on February 10,2018, 1/3 on February 10,2019 and 1/3 on February 10,2020. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:59 UTC |
Albers Robert JohnDirector
|
GrantOption to Purchase Common Stock · Derivative | 21,000 | $4.79 Strike: $4.79 | $100,590.00 |
DisclosureSEC source: 0001209191-17-010733 · doc4.xml · derivative · entry 1 Albers Robert John · CIK 0001425879 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: MII Common Stock · 21,000 shares Expires 2027-02-10 F1 · derivative.exercise_date: Options vest 1/3 on February 10,2018, 1/3 on February 10,2019 and 1/3 on February 10,2020. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:55 UTC |
ROWLAND MARCUS CDirector
|
GrantOption to Purchase Common Stock · Derivative | 21,000 | $4.79 Strike: $4.79 | $100,590.00 |
DisclosureSEC source: 0001209191-17-010709 · doc4.xml · derivative · entry 1 ROWLAND MARCUS C · CIK 0001039535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: MII Common Stock · 21,000 shares Expires 2027-02-10 F1 · derivative.exercise_date: Options vest 1/3 on February 10,2018, 1/3 on February 10,2019 and 1/3 on February 10,2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.